No Data
Haoyuan Pharmaceutical (688131.SH): In 2024, continue to deepen the Global Strategy and accelerate the expansion of overseas markets.
On January 20, Gelonghui reported that Haoyuan Pharmaceutical (688131.SH) recently stated during a meeting with institutional investors that in 2024, the company will continue to deepen its Global Strategy and accelerate the expansion of overseas markets. In the life sciences reagent business Sector, the company's global layout has begun to show results, with warehouse centers in Europe, the USA, and India fully speeding up operations, successfully establishing an efficient collaborative network between overseas business centers and domestic front warehouses. Additionally, with the ongoing upgrades of the business team, overseas business in the front end has achieved steady growth. Moreover, relying on overseas business logistics centers, on one hand, through high difficulties and high-value-added molecular building blocks and functions.
Private Companies Are Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Biggest Owners and Were Hit After Market Cap Dropped CN¥485m
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Haoyuan Pharmaceutical (688131.SH) disclosed the results of the convertible bonds lottery: there are a total of 0.2674 million winning numbers.
On December 1st, Gelonghui reported that Haoyuan Pharmaceutical (688131.SH) announced the results of the online lottery for the issuance of convertible corporate bonds to unspecified objects, and the lottery results are as follows: Investors participating in the online subscription of Haoyuan convertible bonds whose subscription allocation number ending matches the above numbers will be considered as winning numbers. There are a total of 267,408 winning numbers, and each winning number can only subscribe for 1 lot (1,000 yuan) of Haoyuan convertible bonds.
Haoyuan Pharmaceutical (688131.SH): "Haoyuan Convertible Bonds" will open for subscription on November 28th.
Haoyuan Medicine (688131.SH) announced that the company's convertible bonds issued this time are referred to as 'Haoyuan Convertible...'.
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) 36% Price Boost Is Out Of Tune With Earnings
Shanghai Haoyuan Chemexpress Co., Ltd.'s (SHSE:688131) P/E Is Still On The Mark Following 31% Share Price Bounce
